Nivolumab for metastatic renal cell carcinoma (mRCC): Results of a randomized, dose-ranging phase II trial Meeting Abstract
| Authors: | Motzer, R. J.; Rini, B. I.; McDermott, D. F.; Redman, B. G.; Kuzel, T.; Harrison, M. R.; Vaishampayan, U. N.; Drabkin, H. A.; George, S.; Logan, T. F.; Margolin, K. A.; Plimack, E. R.; Waxman, I.; Lambert, A.; Hammers, H. J. |
| Abstract Title: | Nivolumab for metastatic renal cell carcinoma (mRCC): Results of a randomized, dose-ranging phase II trial |
| Meeting Title: | 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 32 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2014 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2014-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358613203403 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2014.32.15_suppl.5009 |
| Notes: | Meeting Abstract: 5009 -- Source: Wos |
